(PCRX) Pacira Pharmaceuticals Monthly charts technical analysis
(PCRX) Pacira Pharmaceuticals Monthly charts technical analysis Monthly analysis of Pacira Pharmaceuticals | Buy/Sell Pacira Pharmaceuticals
Pacira Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Pacira Pharmaceuticals is 719490
| Date | Closing Price | Open | High | Low | Volume |
| 05 Fri Dec 2025 | 23.99 | 23.49 | 24.81 | 23.29 | 3.272 Mn |
| 28 Fri Nov 2025 | 23.57 | 21.78 | 24.95 | 20.32 | 13.875 Mn |
| 31 Fri Oct 2025 | 21.38 | 25.80 | 26.05 | 19.84 | 12.49 Mn |
| 30 Tue Sep 2025 | 25.77 | 26.63 | 27.64 | 24.54 | 12.227 Mn |
| 29 Fri Aug 2025 | 26.67 | 21.24 | 27.03 | 20.93 | 16.529 Mn |
| 31 Thu Jul 2025 | 21.09 | 23.85 | 24.36 | 20.85 | 11.928 Mn |
| 30 Mon Jun 2025 | 23.90 | 25.93 | 27.42 | 23.24 | 10.801 Mn |
| 30 Fri May 2025 | 25.84 | 26.66 | 27.34 | 23.00 | 18.415 Mn |
| 30 Wed Apr 2025 | 26.90 | 24.67 | 27.64 | 21.79 | 20.316 Mn |
| 31 Mon Mar 2025 | 24.85 | 24.04 | 25.88 | 21.83 | 15.661 Mn |
Indicators analysis of Pacira Pharmaceuticals (PCRX)
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Pacira Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Pacira Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Pacira Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Pacira Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Pacira Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 24.72 and Pacira Pharmaceuticals (PCRX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Pacira Pharmaceuticals (PCRX) stock. Volume based technical analysis of Pacira Pharmaceuticals (PCRX) stock is negative.
Pacira Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Monthly charts
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Pacira Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Pacira Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Pacira Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Pacira Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Pacira Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 24.72 and Pacira Pharmaceuticals (PCRX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Pacira Pharmaceuticals (PCRX) stock. Volume based technical analysis of Pacira Pharmaceuticals (PCRX) stock is negative.
Pacira Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.